Análisis de la acción Sharps Technology Inc (STSS)STSSSharps Technology Inc

SkyAI, Inc., formerly Sharps Technology, Inc., is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Sharps Technology Inc (STSS), now rebranding to SkyAI, is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The current setup is weak technically, insider selling is rising sharply, and there is no strong proprietary buy signal. Even with the pre-market price at 1.84, the stock is below the pivot and under bearish moving averages, so I would not buy it now. My direct view: sell/avoid for now, not a buy.